CIK 0001444192
- Non-accelerated filer
- Smaller reporting company
Grace Therapeutics, Inc.
Sign in to watch- Ticker
- GRCE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 609-322-1602
- Business address
- 103 CARNEGIE CENTER, SUITE 300, PRINCETON, NJ, 08540
- Former names
- Acasti Pharma Inc.
- Open-market buys, last 90 days
- $814,975
- in 11 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$814,975. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-17 | Kavuru Vimal Director | Grant or award · Stock Option (Right to Buy) | +12,200 | 12,200 | ||
| 2026-01-08 | Kavuru Vimal Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2025-05-09 | Kavuru Vimal Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2023-12-19 | Kavuru Vimal Director | Grant or award · Stock Options (Right to Buy) | +10,000 | 10,000 | ||
| 2023-09-25 | Kavuru Vimal Director | Purchase | +676,371 | $1.85 | $1.2M | 1,188,076 |
| 2023-09-25 | Kavuru Vimal Director | Purchase · Common Warrants (right to buy) | +422,732 | $0.13 | $53K | 422,732 |
| 2023-07-14 | Kavuru Vimal Director | Grant or award · Stock Options (Right to Buy) | +12,500 | 12,500 | ||
| 2022-09-28 | Kavuru Vimal Director | Grant or award · Stock Options (Right to Buy) | +45,000 | 45,000 | ||
| 2021-11-12 | Kavuru Vimal Director | Grant or award · Stock Options (Right to Buy) | +42,100 | 42,100 |
Page 1 of 1 · 9 trades